Mounjaro® price changes from 1 September 2025 - what this means for SemaPen patients

Simon Edward • 15 August 2025

Mounjaro® price changes from 1 September 2025 - what this means for SemaPen patients

Eli Lilly & Company has confirmed that the UK list price for Mounjaro (tirzepatide) will increase from 1 September 2025, bringing it in line with prices in other developed countries.


Our pharmacy partners have now confirmed that they are out of stock at current prices. This means any new Mounjaro supply will be subject to the new, higher pricing once stock resumes. We expect to have final patient prices confirmed tomorrow afternoon and will update all SemaPen patients immediately.


It’s important to note that Wegovy prices are not affected by this change. For some patients, Wegovy may be a safe and effective alternative if Mounjaro becomes unaffordable. Any change in medication will always be done under clinical supervision.

We know this situation is unsettling. Our priority is to keep treatment accessible and minimise disruption to your care. We’ll send another update tomorrow with confirmed pricing.



SemaPen – your trusted partner in safe, effective weight-loss treatment.

Discover why weight loss naturally slows over time, and learn how to move past plateaus
by Simon Edward 29 December 2025
Discover why weight loss naturally slows over time, and learn how to move past plateaus with confidence.
Learn about the main clinical trials for Wegovy (semaglutide), including STEP, SURMOUNT, FLOW
by Simon Edward 26 December 2025
Learn about the main clinical trials for Wegovy (semaglutide), including STEP, SURMOUNT, FLOW and ESSENCE.
Trulicity is not an approved treatment for weight loss, but Wegovy and Mounjaro are effective
by Simon Edward 22 December 2025
Trulicity is not an approved treatment for weight loss, but Wegovy and Mounjaro are effective and approved alternatives. Learn more in our guide.
What, exactly, is class 3 obesity? What about class 1 and class 2? Learn about the different obesity
by Simon Edward 20 December 2025
What, exactly, is class 3 obesity? What about class 1 and class 2? Learn about the different obesity classes and what they mean for our health.
Body aches aren't listed as a side effect of Wegovy.
by Simon Edward 15 December 2025
Body aches aren't listed as a side effect of Wegovy. So, why do so many people report feeling achy or tired? Join us as we explore the facts.
Most adults should eat 600 fewer calories per day to lose weight. But there's more to weight loss
by Simon Edward 8 December 2025
Most adults should eat 600 fewer calories per day to lose weight. But there's more to weight loss than calories alone. Learn why in our guide.
You might have heard that Mounjaro is linked with depression and anxiety. Let's look at the facts
by Simon Edward 5 December 2025
You might have heard that Mounjaro is linked with depression and anxiety. Let's look at the facts behind the claims.
Did you know that people living with obesity are more likely to be smokers? Let's explore the links
by Simon Edward 4 December 2025
Did you know that people living with obesity are more likely to be smokers? Let's explore the links between smoking and body weight.
Mazdutide is a GLP-1 injection that works similarly to Mounjaro. Discover everything you need
by Simon Edward 1 December 2025
Mazdutide is a GLP-1 injection that works similarly to Mounjaro. Discover everything you need to know about this up-and-coming weight loss drug.
Want to know if you're eligible to take Mounjaro? Discover the threshold BMI for Mounjaro
by Simon Edward 29 November 2025
Want to know if you're eligible to take Mounjaro? Discover the threshold BMI for Mounjaro in private and NHS settings.
More posts